Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048281 · ClinicalTrials.gov registry record
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
A clinical trial of Esophageal Cancer and Stomach Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01048281 is a study of Esophageal Cancer and Stomach Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01048281, a study of Esophageal Cancer and Stomach Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.
Conditions Studied
Interventions
- PROCEDURE Blood draw
- PROCEDURE Tissue tumor biopsy
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-08 |
| Est. Completion | 2099-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01048281
The ClinicalTrials.gov registry entry for NCT01048281 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.
NCT01048281 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01048281 about?
NCT01048281 is a clinical study titled "Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma". Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn ...
What is the current status of trial NCT01048281?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2002-08. Estimated completion is 2099-01.
What conditions does trial NCT01048281 study?
This clinical trial studies the following conditions: Esophageal Cancer, Stomach Cancer, Gastrointestinal Stromal Tumor (GIST), Gastric (Stomach) Cancer, Gastro-Esophageal(GE) Junction Cancer.
What interventions are being tested in trial NCT01048281?
The interventions under investigation include: Blood draw (PROCEDURE), Tissue tumor biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01048281?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01048281 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.